| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.051 | 0.2 |